2004
DOI: 10.1007/s11926-004-0084-2
|View full text |Cite
|
Sign up to set email alerts
|

An update on bisphosphonates

Abstract: Over the past 15 years, bisphosphonates have been demonstrated as effective therapy for the treatment of osteoporosis based on their ability to suppress bone turnover resulting in increased bone mineral content and increased bone strength. The mechanism of action at the cellular level has been identified, and the more potent nitrogen-containing bisphosphonates clearly have reduced the risk of vertebral and nonvertebral fractures in patients with osteoporosis. Future use of these therapies is evolving to less f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0
1

Year Published

2004
2004
2021
2021

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(9 citation statements)
references
References 43 publications
(31 reference statements)
0
8
0
1
Order By: Relevance
“…Examples of critical medical importance include systemic amyloidoses, neurodegenerative diseases, and prion-related encephalopathies (57,58). In such pathological processes proteins lose their native structures and undergo cross-␤ assembly to form fibrils (59,60).…”
Section: Discussionmentioning
confidence: 99%
“…Examples of critical medical importance include systemic amyloidoses, neurodegenerative diseases, and prion-related encephalopathies (57,58). In such pathological processes proteins lose their native structures and undergo cross-␤ assembly to form fibrils (59,60).…”
Section: Discussionmentioning
confidence: 99%
“…Increased osteoclast activity and bone turnover rate are known pathological characteristics of subchondral bone in OA, particularly at early stage. For this reason, the common anti-resorptive medicine, bisphosphonate, has been tested its efficacy for treating OA in many clinical trials 134 . Though the outcome in human subjects was not as encouraging as in animal OA models 135139 , specific drugs within the bisphosphonate class did show benefit effects in a few human studies.…”
Section: Modulation Of Tgfβ Activity In Subchondral Bone As a Potentimentioning
confidence: 99%
“…Bisphosphonates are a class of synthetic analogs of pyrophosphate, which have been widely used for treatment of different diseases characterized by intense bone resorption, such as Paget's disease, osteoporosis, multiple myeloma, bone metastases of breast and prostate tumors (1)(2)(3). These drugs inhibit bone resorption mainly by inhibiting osteoclast differentiation and activity (4).…”
Section: Introductionmentioning
confidence: 99%